Our Research Focus

TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD™ lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy.

Our Pipeline

TLC has a robust pipeline of early- to late-stage programs in the areas of pain management, ophthalmology, and oncology.

More About TLC